Novak joins Fate Therapeutics
Fate Therapeutics Inc. has named Tom Novak, Ph.D., as vice president of research and drug discovery.
He has more than 15 years of experience working with large pharmaceutical companies, including Roche and Wyeth. Novak will be responsible for Fate’s drug discovery and development activities focused on advancing the company’s pipeline of “stem cell modulators,” small molecules or biologics that guide cell
fate in vivo for therapeutic benefit.